A novel alanine to serine substitution mutation in SoxS induces overexpression of efflux pumps and contributes to multidrug resistance in clinical Escherichia coli isolates
Authors:
Open Access
- 28 April 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 70 (8) , 2228-2233
Abstract
The purpose of this study was to describe a putative role for a novel soxS mutation in contributing to multiple-antibiotic resistance in canine fluoroquinolone-associated MDR (FQ-MDR) Escherichia coli. This soxS mutation was discovered in canine faecal E. coli isolates during a study investigating the effect of oral fluoroquinolone administration on faecal E. coli in healthy dogs. We determined via quantitative real-time RT–PCR that both soxS and acrB were overexpressed in the clinical soxS Ala-12→Ser (soxSA12S) mutants and this may account for their FQ-MDR phenotype. We validated the FQ-MDR phenotype of the clinical isolates by reconstructing the WT and the soxSA12S mutation in the E. coli soxS null mutant JW4023 (soxS::kn) via allelic exchange. The JW4023 soxSA12S derivative showed an increase in MICs of ciprofloxacin, enrofloxacin and chloramphenicol compared with the JW4023 derivative in which the WT soxS had been restored. The soxS and acrB genes were overexpressed in the JW4023 soxSA12S mutant compared with JW4023 with WT soxS. A similar overexpression of efflux pump genes and an increase in antibiotic resistance were observed upon stimulation with paraquat to resemble the phenotype of the clinical soxSA12S isolates. Our data suggest that the soxSA12S substitution mutation is selected in clinical isolates when dogs are exposed to a fluoroquinolone and that this mutation contributes to the FQ-MDR phenotype of E. coli isolates.Keywords
Funding Information
- Auburn University Intramural Grants Program (AU-IGP 2010)
- United States Department of Agriculture (2005-3439415674A)
- Auburn University Detection and Food Safety Peaks of Excellence Program
- National Science Foundation (EPS 11-58862 to S.-J. S, .)
This publication has 20 references indexed in Scilit:
- Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animalsVeterinary Microbiology, 2012
- Molecular mechanisms of antimicrobial resistance in fecal Escherichia coli of healthy dogs after enrofloxacin or amoxicillin administrationCanadian Journal of Microbiology, 2012
- Expression of Multidrug Efflux Pump Genes acrAB-tolC , mdfA , and norE in Escherichia coli Clinical Isolates as a Function of Fluoroquinolone and Multidrug ResistanceAntimicrobial Agents and Chemotherapy, 2011
- Antimicrobial Resistance Profiles and Clonal Relatedness of Canine and Feline Escherichia coli Pathogens Expressing Multidrug Resistance in the United StatesJournal of Veterinary Internal Medicine, 2010
- Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteriaBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coliJournal of Antimicrobial Chemotherapy, 2006
- Genome-Wide Transcriptional Profiling of the Escherichia coli Responses to Superoxide Stress and Sodium SalicylateJournal of Bacteriology, 2001
- Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulonAntimicrobial Agents and Chemotherapy, 1997
- The Redox State of the [2Fe-2S] Clusters in SoxR Protein Regulates Its Activity as a Transcription FactorJournal of Biological Chemistry, 1996
- Multidrug efflux pumps of gram-negative bacteriaJournal of Bacteriology, 1996